You are here: Industry Insights > small molecules

News List

Novel automated production technique could revolutionise production of small molecules europeanpharmaceuticalreview
June 03, 2021
The new automated active pharmaceutical ingredient production technique, solid phase synthesis-flow (SPS-flow), enables push-button automated multi-step synthesis of small molecules.
NiKang Therapeutics secures $200m in Series C funding pharmaceutical-technology
May 28, 2021
NiKang Therapeutics has secured $200m in a Series C funding round to develop new small molecules for difficult-to-drug targets in oncology indications.
Lonza to Build Small Molecule Manufacturing Complex in Visp contractpharma
April 25, 2021
Lonza, a contract development and manufacturing organization (CDMO) partner to the biopharma industry, is investing CHF 200 million (~$220mn) in the construction of a new small molecule manufacturing complex at its Visp site in Switerland.
New technique for identifying small molecules may speed up drug discovery, manufacturing worldpharmanews
November 29, 2018
A UCLA-led team of scientists has developed a new technique that will enable researchers to easily and quickly determine the structures of organic molecules using very small samples.
Bay Area Biotech Company Inked Multi-Year Research Deal with Genentech biospace
December 20, 2017
less than two years after tying up a multi-billion deal with Sanofi, DiCE Molecules scored another collaborative deal. The Bay Area company inked a multi-year collaborative agreement with Genentech to discover new small molecules.
Regen Addresses Potential Impact of Bristol Myers Squibb's $2.3 Billion Acquisition of IFM americanpharmaceuticalreview
August 11, 2017
On August 3, 2017 Bristol Myers Squibb (BMS) announced that it had entered into an agreement to acquire IFM Therapeutics, a smaller biotech company focused on developing therapies that modulate novel targets in the innate immune system to treat cancer, au
Merck KGaA, Domain Explore New Immuno-oncology Agents contractpharma
January 24, 2017
Will work to develop and test new agents targeting key adenosine receptors